To the full analysis
VERBIO Vereinigte BioEnergie stock: growth
VBK.DEVERBIO Vereinigte BioEnergie reported $2.08B in revenue for fiscal 2026, up 18.5% on the prior year, up 12.8% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
8.8%
per year from 2008 to 2026, per share 8.7%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2008 | |
|---|---|---|---|
| Revenue | 12.8% | 11.1% | 8.8% |
| Revenue per share | 12.5% | 10.9% | 8.7% |
| Earnings | −7.3% | 2.7% | no data |
| Earnings per share | −7.5% | 2.6% | no data |
| Free cash flow | 9.4% | 2.2% | no data |
| Free cash flow per share | 9.1% | 2.0% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2008 | $453.75M | −$272.98M | −$142.61M |
| 2009 | $740.72M | $10.06M | $65.71M |
| 2010 | $551.75M | −$8.05M | −$64.98M |
| 2011 | $576.85M | $8.85M | −$10.82M |
| 2012 | $835.48M | $1.18M | −$40.2M |
| 2013 | $781.47M | −$169M | −$61.9M |
| 2014 | $813.09M | $5.83M | $76.34M |
| 2015 | $685.35M | $29.67M | $36.52M |
| 2016 | $725.06M | $54.02M | $69.96M |
| 2017 | $804.97M | $57.07M | $62.57M |
| 2018 | $760.04M | $16.54M | −$15.82M |
| 2019 | $863.56M | $58.69M | $49.09M |
| 2020 | $966.7M | $70.23M | $3.96M |
| 2021 | $1.14B | $103.28M | $55.3M |
| 2022 | $2.01B | $349.74M | $232.87M |
| 2023 | $2.18B | $146.3M | −$196.27M |
| 2024 | $1.85B | $22.12M | −$60.26M |
| 2025 | $1.75B | −$152.93M | −$130.71M |
| 2026 | $2.08B | $70.83M | $86.84M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Jun 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 17 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.